Amedisys Cash Flow - Quarterly (NASDAQ:AMED)

Add to My Stocks
$120.1 $0.61 (0.51%) AMED stock closing price Sep 18, 2018 (Closing)

For analyzing any company like Amedisys from an investment perspective, its important to check the cash flow statement. While its important to look at the Amedisys debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Amedisys revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Amedisys stock analysis shows positive net income cash flow of $60.86M till 2018 Q2. This statement is important because profits alone cannot pay employees, or bills. Cash is required. The cash from operating activities for Amedisys is $ 2018 Q2, which saw an increase from previous quarter.

View and download details of Amedisys cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
60.86M27.32M30.68M34.38M19.72M15.19M37.63M28.65M17.15M6.31M
Depreciation Depletion Amortization Cash-Flow7.07M3.77M17.85M13.69M9.32M4.6M20.41M15.21M9.81M4.65M
Net Increase (Decrease) in Assets Liabilities3.13M--48.35M-29.66M1.8M-14.83M-67.07M-59.08M-31.4M-13.24M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net19.91M8.88M105.54M55.12M32.48M22.12M71.28M48.91M31.32M14.51M
Net Cash from (used by) Operating Activities
90.97M40.31M105.73M73.54M63.34M27.09M62.25M33.69M26.89M12.24M
Increase (Decrease) in Prop Plant And Equipment-1.6M-1.45M-10.45M-8.33M-6.88M-4.38M-15.71M-13.5M-9.68M-6.7M
Acquisition Disposition of Subsidiaires-4.07M-2.25M-33.71M-24.12M-24.12M-4.09M-35.52M-31.37M-27.63M-27.68M
Increase (Decrease) in Investments---0.47M-0.43M-0.43M-0.25M-1.04M-0.75M-0.43M-
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
-5.2M-3.24M-44.02M-32.89M-31.44M-8.17M-52.04M-45.4M-37.75M-34.15M
Issuance (Purchase) of Equity Shares-180.47M-0.58M--0.44M-0.33M--9.83M-10.49M-11.1M-11.67M
Issuance (Repayment) of Debt Securities-90.48M--5.31M-4.06M-2.5M-1.25M-5M-3.75M-2.5M-1.25M
Increase (Decrease) in Bank & Other Borrowings127.5M-2.81M-------15M
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-2.78M-0.02M-0.21M-0.21M-0.09M-0.04M7.31M7.36M6.93M-
Net Cash from (used by) Financing Activities
-146.23M-3.43M-5.53M-4.72M-2.92M-0.78M-7.51M-6.88M-6.67M2.23M
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
-60.46M33.64M56.16M35.91M28.96M18.13M2.69M-18.58M-17.53M-19.67M
Cash & Equivalents at Beginning of Year86.36M30.19M27.5M8.03M17.3M14.54M48M120.29M34.48M2.84M
Cash & Equivalents at Year End25.9M120M86.36M66.11M59.16M48.33M30.19M8.91M9.96M7.82M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Amedisys stock price history provides insight into historical stock price fluctuations, and Amedisys stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Amedisys is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Amedisys stock price movement.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a positive value of $90.97M for AMED.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-5.2M for AMED stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $-146.23M for Amedisys.

Key Financial Ratios For Amedisys Cash Flow

FCF margin
0.12

Quarterly Cash Flow Statements For Amedisys Inc Peers

Chemed cash flow, Civitas cash flow, ENVISION HLTHCR cash flow